Screener
Rhythm Pharmaceuticals, Inc. RYTM Free cash flow
Discontinued — last reported Q4 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.
The source filing: Rhythm Pharmaceuticals, Inc.’s 10-K, filed February 26, 2026. Open the filing →
- Filed
- Feb 26, 2026, 5:02 PM EST
- Fiscal year
- FY2025
- Accession
- 0001628280-26-012399
FAQ
- What is Rhythm Pharmaceuticals, Inc.'s free cash flow?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported free cash flow of -$29.16M in Q4 2025.
- How has Rhythm Pharmaceuticals, Inc.'s free cash flow changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s free cash flow decreased by 2.4% year-over-year, from -$28.47M to -$29.16M.
- What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s free cash flow?
- Over 4 years (2021 to 2025), Rhythm Pharmaceuticals, Inc.'s free cash flow has grown at a -5.5% compound annual growth rate (CAGR), from -$146.44M to -$116.63M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Rhythm Pharmaceuticals, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude